JP2020111620A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020111620A5 JP2020111620A5 JP2020077140A JP2020077140A JP2020111620A5 JP 2020111620 A5 JP2020111620 A5 JP 2020111620A5 JP 2020077140 A JP2020077140 A JP 2020077140A JP 2020077140 A JP2020077140 A JP 2020077140A JP 2020111620 A5 JP2020111620 A5 JP 2020111620A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- alanine
- acid
- amino acids
- oxidase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021139289A JP2021181500A (ja) | 2016-05-27 | 2021-08-27 | リポ多糖およびリピドａの阻害のためのミエロペルオキシダーゼ組成物および方法 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662342382P | 2016-05-27 | 2016-05-27 | |
| US62/342,382 | 2016-05-27 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018549315A Division JP6713546B2 (ja) | 2016-05-27 | 2017-04-13 | リポ多糖およびリピドａの阻害のためのミエロペルオキシダーゼ組成物および方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021139289A Division JP2021181500A (ja) | 2016-05-27 | 2021-08-27 | リポ多糖およびリピドａの阻害のためのミエロペルオキシダーゼ組成物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020111620A JP2020111620A (ja) | 2020-07-27 |
| JP2020111620A5 true JP2020111620A5 (enExample) | 2021-02-04 |
Family
ID=60411564
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018549315A Active JP6713546B2 (ja) | 2016-05-27 | 2017-04-13 | リポ多糖およびリピドａの阻害のためのミエロペルオキシダーゼ組成物および方法 |
| JP2020077140A Withdrawn JP2020111620A (ja) | 2016-05-27 | 2020-04-24 | リポ多糖およびリピドａの阻害のためのミエロペルオキシダーゼ組成物および方法 |
| JP2021139289A Withdrawn JP2021181500A (ja) | 2016-05-27 | 2021-08-27 | リポ多糖およびリピドａの阻害のためのミエロペルオキシダーゼ組成物および方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018549315A Active JP6713546B2 (ja) | 2016-05-27 | 2017-04-13 | リポ多糖およびリピドａの阻害のためのミエロペルオキシダーゼ組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021139289A Withdrawn JP2021181500A (ja) | 2016-05-27 | 2021-08-27 | リポ多糖およびリピドａの阻害のためのミエロペルオキシダーゼ組成物および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11389514B2 (enExample) |
| EP (1) | EP3463431B1 (enExample) |
| JP (3) | JP6713546B2 (enExample) |
| CN (1) | CN109414485B (enExample) |
| AU (1) | AU2017269582B2 (enExample) |
| CA (1) | CA3022426C (enExample) |
| IL (1) | IL262930B2 (enExample) |
| MX (1) | MX392701B (enExample) |
| WO (1) | WO2017204918A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020014493A1 (en) * | 2018-07-13 | 2020-01-16 | Allen Robert C | Haloperoxidase compositions and uses thereof |
| WO2022103565A1 (en) * | 2020-11-13 | 2022-05-19 | Exoxemis, Inc. | Myeloperoxidase-containing compositions and uses thereof |
| WO2024126571A1 (en) * | 2022-12-14 | 2024-06-20 | Universite de Bordeaux | Artificial bifunctional enzyme comprising a myeloperoxidase activity and a glucose oxidase activity and applications thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2108387B (en) | 1979-12-28 | 1984-03-21 | Green Cross Corp | A pharmaceutical composition containing myeloperoxidase |
| US5089274A (en) * | 1989-02-14 | 1992-02-18 | Incyte Pharmaceuticals, Inc. | Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat endotoxin-related disorders |
| US5622848A (en) * | 1990-05-23 | 1997-04-22 | Medical Discoveries, Inc. | Electrically hydrolyzed salines as microbiocides for in vitro treatment of contaminated fluids containing blood |
| US5565197A (en) * | 1991-02-21 | 1996-10-15 | Exoxemis, Inc. | Method which utilizes a haloperoxidase composition to inhibit the growth of microorganisms which cause sexually transmitted diseases |
| US5389369A (en) * | 1991-02-21 | 1995-02-14 | Exoxemis, Inc. | Halo peroxidase containing compositions for killing yeast and sporular microorganisms |
| US5888505A (en) * | 1991-02-21 | 1999-03-30 | Eoe, Inc. | Method for selectively inhibiting the growth of microbes using a haloperoxidase-halide-peroxide system |
| WO1992014484A1 (en) * | 1991-02-21 | 1992-09-03 | Exoxemis, Inc. | Methods and compositions for the treatment of infection and control of flora |
| US8945540B2 (en) * | 2008-05-09 | 2015-02-03 | Exoxemis, Inc. | Compositions for enhancing the antibacterial activity of myeloperoxidase and methods of use thereof |
| CA2839747A1 (en) * | 2011-07-11 | 2013-01-17 | Exoxemis, Inc. | Eosinophil peroxidase compositions and methods of their use |
-
2017
- 2017-04-13 IL IL262930A patent/IL262930B2/en unknown
- 2017-04-13 JP JP2018549315A patent/JP6713546B2/ja active Active
- 2017-04-13 US US16/302,449 patent/US11389514B2/en active Active
- 2017-04-13 AU AU2017269582A patent/AU2017269582B2/en active Active
- 2017-04-13 EP EP17803212.4A patent/EP3463431B1/en active Active
- 2017-04-13 CN CN201780032711.9A patent/CN109414485B/zh active Active
- 2017-04-13 CA CA3022426A patent/CA3022426C/en active Active
- 2017-04-13 WO PCT/US2017/027458 patent/WO2017204918A1/en not_active Ceased
- 2017-04-13 MX MX2018013925A patent/MX392701B/es unknown
-
2020
- 2020-04-24 JP JP2020077140A patent/JP2020111620A/ja not_active Withdrawn
-
2021
- 2021-08-27 JP JP2021139289A patent/JP2021181500A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2010150428A (ru) | Композиции для усиления антибактериальной активности миелопероксидазы и способы их применения | |
| JP2020111620A5 (enExample) | ||
| US20130071439A1 (en) | Methods and compositions for treating biofilms | |
| CA2177195A1 (en) | Method and composition for treating renal failure | |
| JP2009526751A5 (enExample) | ||
| WO2012151554A1 (en) | Polyamines for treating biofilms | |
| BRPI0808333B1 (pt) | Extrato bacteriano para doenças respiratórias e processo para sua preparação | |
| JP2014520853A (ja) | 好酸球ペルオキシダーゼ組成物およびその使用方法 | |
| JP2019515881A5 (enExample) | ||
| CA2613464A1 (en) | Treatment of dry eye | |
| JPS568312A (en) | Amino acid pharmaceutical preparation | |
| ATE272399T1 (de) | Zusammensetzungen aus aminosäuren zur behandlung von herzinsuffizienz | |
| JP2006524182A5 (enExample) | ||
| JP2019515881A (ja) | リポ多糖およびリピドａの阻害のためのミエロペルオキシダーゼ組成物および方法 | |
| WO2000033852B1 (en) | Compound and method for degrading amino acids | |
| AU685585B2 (en) | Analgesic activity enhancer | |
| TW202416946A (zh) | 液體達巴萬星組成物 | |
| ATE487390T1 (de) | Proteinzusammensetzung zur behandlung eines physiologisch bedingten, klinisch unauffälligen proteinmehrbedarfs | |
| WINITZ et al. | Quantitative nutritional and in vivo metabolic studies with water-soluble, chemically defined diets | |
| JPH02121928A (ja) | Ｌ−チロシンのジペプチドを含有する栄養輸液組成物 | |
| RU2022133861A (ru) | Раствор для лечения вульвовагинальных и внутриматочных заболеваний | |
| JPH02119762A (ja) | Ｌ−グルタミンのオリゴペプチド配合栄養組成物 | |
| ES2132021A1 (es) | Formulas de aminoacidos para personas de la tercera edad y procedimiento para el calculo de las mismas. | |
| CN1753663A (zh) | 用α2δ亚单位钙通道调节剂治疗无疼膀胱病症的方法 | |
| HU200561B (en) | Solution set from natural agents for setting, cleaning and storing hard, gas-permeable contact lenses |